Yahoo Search Búsqueda en la Web

Resultado de búsqueda

  1. Hace 2 días · AbstractPurpose:. To determine the efficacy and safety of risk-adapted combinations of androgen signaling inhibitors and inform disease classifiers for metastatic castration–resistant prostate cancers.Patients and Methods:. In a modular, randomized phase II trial, 192 men were treated with 8 weeks of abiraterone acetate, prednisone, and apalutamide (AAPA; module 1) and then allocated to ...

  2. Hace 2 días · Additionally, Dr. Padmanee Sharma, MD, PhD, Associate Vice President of Immunobiology and Professor at The University of Texas MD Anderson Cancer Center, received the Outstanding Scientist Award ...

  3. 10 de may. de 2024 · 作者:Padmanee Sharma; Bilal A. Siddiqui; Swetha Anandhan; Shalini S. Yadav; Sumit K. Subudhi; et al 出版日期:2021-04-01 求助人

  4. 29 de may. de 2024 · 9553 Background: Combination immune-checkpoint inhibitors (ICIs) improved outcomes in a plethora of cancer subtypes. However, up to 60% of patients (pts) receiving ipilimumab (ipi) plus nivolumab (nivo) experience grade 3/4 (G 3/4) immune-related adverse events (irAEs), often leading to treatment discontinuation. We evaluated two therapeutic strategies targeting interleukin-6 receptor (IL-6R ...

  5. 14 de may. de 2024 · 其它: 期刊:Cell 作者:Padmanee Sharma; Sangeeta Goswami; Deblina Raychaudhuri; Bilal A. Siddiqui; Pratishtha Singh; et al 出版日期:2023-04-01

  6. Hace 3 días · Padmanee Sharma 与丈夫 James Allison 图片来源:帕克癌症免疫疗法研究所官网. Sharma 教授是免疫学界的重量级人物,在 MD 安德森癌症中心担任要职。她的研究在免疫治疗领域具有开创性意义。

  7. Hace 3 días · Padmanee Sharma, MD, PhD. Professor, Department of Genitourinary Medical Oncology; Professor, Department of Immunology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX